Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07245667
PHASE2

Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study

Sponsor: Propedix, Inc.

View on ClinicalTrials.gov

Summary

This study is designed to evaluate the safety and effectiveness of multiple 1% tolnaftate formulations delivered through novel stick-based vehicles in individuals with tinea pedis (athlete's foot).

Official title: Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis

Key Details

Gender

All

Age Range

16 Years - Any

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2024-12-30

Completion Date

2026-02

Last Updated

2025-11-28

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

1% Tolnaftate Stick Formula A

Topical antifungal stick containing 1% tolnaftate in the Formula A base. Applied twice daily for 4 weeks.

DRUG

1% Tolnaftate Stick Formula B

Topical antifungal stick containing 1% tolnaftate in the Formula B base. Applied twice daily for 4 weeks.

DRUG

1% Tolnaftate Stick Formula C

Topical antifungal stick containing 1% tolnaftate in the PP2C-2003 base formulation. Applied twice daily for 30 days.

Locations (2)

Kuchnir Dermatology and Dermatological Surgery

Framingham, Massachusetts, United States

Kuchnir Dermatology and Dermatological Surgery

Milford, Massachusetts, United States